Pavmed Inc (PAVM) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PAVM Annual Cash Flow →
Quarterly cash flow trends provide additional context on Pavmed Inc's liquidity and ability to support ongoing operations and capital needs.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-20.13
Depreciation & amortization0.04
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Intangible Assets0.00
Share-based Compensation3.05
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-1.83
Loss On The Issuance Of Preferred Stock Units-
Embedded Derivative Gain Loss On Embedded Derivative Net-
Change In Fair Value Of Series Convertible Preferred Stock Conversion Option Derivative Liability-
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest-
Interest Expense Accrued Senior Secured Note-
Interest Expense Amortization Of Debt Discount Senior Secured Note-
Change In Fair Value Senior Secured Convertible Note-
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost3.42
Deconsolidation Gain Or Loss Amount-
Debt Instrument Change In Fair Value-3.36
Income taxes0.00
Losses/ -gains on Investments net-0.63
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.38
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-0.02
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.42
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net-2.22
Payments for (Proceeds from) Other Operating Activities15.66
Discontinued operations0.00
Net Cash flow from Operating Activities-5.28
Investing Activities
Capital Expenditures-0.04
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Decrease In Cash Due To Deconsolidation Of Subsidiary-
Proceeds From Sale Of Property Held For Sales-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.04
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings15.00
Long-term debt - repayments-11.15
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Proceeds from Partnership Contribution0.00
Issuances / -repurchases of Pref. Stock3.71
Increase (Decrease) in Deposits0.00
Other financing activities net0.00
Other net0.00
Proceeds From Common Stock Issued Upon Exercise Of Warrants-
Proceeds From Issuance Of Series A Preferred Stock Units-
Proceeds From Issuance Of Series A1 Preferred Stock Units-
Proceeds From Common Stock Issued Upon Exercise Of Warrants Net-
Proceeds From Issue Of Units In Equity Subscription Rights Offering-
Payment Of Offering Costs Equity Subscription Rights Offering-
Payment Offering Costs Registered Offerings-
Proceeds Issue Units Equity Subscription Rights Offering-
Payment Offering Costs Equity Subscription Rights Offering-
Proceeds Issue Common Stock Majorityowned Subsidiary-
Proceeds From Issuance Of Common Stock Of Majorityowned Subsidiary-
Repayments Of Convertible Debt Non Installment-
Proceeds From Issue Of Common Stock Employee Stock Purchase Plan-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities7.56
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-5.32
Total Cash Flow2.25
4 historic quarters locked

Sign in to unlock the full Pavmed Inc cash flow history.

About Pavmed Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-027733

Figures are derived from filed reports and may be restated. Historical data is subject to revision.